1 min read •
Industrie pharmaceutique : les big pharmas soignent leurs profits
Major pharmaceutical laboratories are well aware that many of their top selling medecines (blockbusters) are reaching the end of their life cycle. That is why they are searching new business models in the short run. According to Arthur D. Little, in one of their studies (2007) the end of those numerous blockbusters should make 25% to 40% of the industry workforce unemployed (22,000 people in total).
Major pharmaceutical laboratories are well aware that many of their top selling medecines (blockbusters) are reaching the end of their life cycle. That is why they are searching new business models in the short run. According to Arthur D. Little, in one of their studies (2007) the end of those numerous blockbusters should make 25% to 40% of the industry workforce unemployed (22,000 people in total).
RELATED INFORMATION
A Conversation Profits with Principles - The Transformation of Royal Dutch/Shell
With more than 100,000 employees and assets valued at $80 billion, the Royal Dutch/Shell Group is a global giant in the energy industry, involved in the whole production process of fossil fuels – –…
The big experiment
The pandemic challenged many industries to rethink — and experiment with — their business models. This prompted the entertainment industry to explore new strategies, catalyzed by the need to recover…
Is nuclear new build more a management than a technology challenge? asks Arthur D. Little
The study concludes that, besides its technical complexity, the management issues of a nuclear new build are often underestimated and call for professional management of the venture. In order to…